101 City Drive South, Orange, CA, 92868 · (714) 456-7890
Beds
911
FY 2025
Star rating
4 of 5
Patient survey: 2 of 5
Net patient revenue
$2.54B
FY 2025
Net income
-$155.7M
Patient care margin -6.1%
Discharges
30,155
Occupancy 92.1%
Clinicians
2,561
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $2.54B | $2.70B | -6.1% | -$155.7M | 30,155 | $29.1M | 20.8% | 5.8% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate after heart bypass surgery | 3.3% | US median 2.3% |
| Death rate for COPD patients | 7.2% | US median 8.5% |
| Death rate for heart attack patients | 12.2% | US median 11.8% |
| Death rate for heart failure patients | 10.3% | US median 11% |
| Hospital-wide death rate within 30 days | 3% | US median 3.9% |
| Death rate for pneumonia patients | 15.1% | US median 15.2% |
| Death rate for stroke patients |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $2.09B | $2.26B | -8.2% | -$1.5M | 24,056 | $46.7M | 20.4% | 8.2% |
| 2023 | $1.90B | $1.94B | -2.5% | $131.2M | 22,163 | $45.2M | 19.3% | - |
| 2022 | $1.66B | $1.76B | -6.2% | $28.7M | 22,651 | $29.7M | 20.2% | 19.2% |
| 2021 | $1.47B | $1.56B | -6.5% | $155.1M | 20,675 | $38.4M | 19.4% | 15.3% |
| 2020 | $1.30B | $1.51B | -15.8% | -$56.5M | 19,931 | $37.0M | 19.2% | 18.7% |
| 10.4% |
| US median 11.6% |
| Readmission rate after heart bypass surgery | 12.9% | US median 10.9% |
| Readmission rate for COPD | 21% | US median 19.8% |
| Readmission rate after a heart attack | 14.6% | US median 14.4% |
| Readmission rate for heart failure | 20.8% | US median 21.3% |
| Readmission rate after hip or knee replacement | 5.8% | US median 5.8% |
| Readmission rate for pneumonia | 16.8% | US median 17.2% |
| Complications after hip or knee replacement | 3.5% | US median 4.1% |
| Serious complications (patient safety composite) | 0.90 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.55 | US median 0.28 · better |
| Central line bloodstream infections (ratio to expected) | 0.56 | US median 0.48 · better |
| Surgical site infections after colon surgery (ratio to expected) | 0.45 | US median 0.72 · better |
| Surgical site infections after hysterectomy (ratio to expected) | 0.55 | US median 0.81 |
| MRSA bloodstream infections (ratio to expected) | 0.36 | US median 0.60 · better |
| Catheter urinary tract infections (ratio to expected) | 0.42 | US median 0.40 · better |
| Doctors always communicated well | 74% | US median 79% |
| Nurses always communicated well | 72% | US median 80% |
| Patient survey summary star rating | 2 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 40% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 65% | US median 72% |
| Room and bathroom always clean | 62% | US median 73% |
| Patients who would definitely recommend the hospital | 67% | US median 71% |
| Patients who left the emergency department before being seen | 2% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 318 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 16% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 66% | US median 65% |
| Healthcare workers given the flu vaccine | 74% | US median 79% |
| 89 |
| $61,536.63 |
| $13,772.80 |
| $7,681.44 |
| DRG 640 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC | 86 | $96,209.66 | $18,591.94 | $10,642.23 |
| DRG 470 MAJOR HIP AND KNEE JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MCC | 73 | $115,370.44 | $24,262.42 | $14,289.25 |
| DRG 698 OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC | 62 | $93,225.65 | $21,729.79 | $13,076.55 |
| DRG 177 RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC | 57 | $111,870.51 | $20,786.56 | $12,667.88 |
| DRG 266 ENDOVASCULAR CARDIAC VALVE REPLACEMENT AND SUPPLEMENT PROCEDURES WITH MCC | 55 | $226,822.82 | $86,551.04 | $52,994.82 |
| DRG 853 INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC | 54 | $454,389.46 | $90,024.06 | $40,556.82 |
| DRG 274 PERCUTANEOUS AND OTHER INTRACARDIAC PROCEDURES WITHOUT MCC | 52 | $144,347.46 | $42,214.04 | $24,748.54 |
| DRG 330 MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH CC | 52 | $149,601.44 | $30,649.58 | $18,026.21 |
| DRG 025 CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH MCC | 50 | $402,677.14 | $76,360.98 | $37,824.45 |
| DRG 064 INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MCC | 49 | $119,311.45 | $23,597.55 | $15,695.20 |
| DRG 267 ENDOVASCULAR CARDIAC VALVE REPLACEMENT AND SUPPLEMENT PROCEDURES WITHOUT MCC | 46 | $180,573.65 | $66,893.26 | $40,566.75 |
| DRG 682 RENAL FAILURE WITH MCC | 45 | $107,012.40 | $20,992.44 | $11,457.18 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5491 Level 1 Intraocular Procedures | 1,628 | 1,017 | $2,275.70 | $1,751.67 |
| APC 5372 Level 2 Urology and Related Services | 815 | 477 | $636.98 | $502.15 |
| APC 8011 Comprehensive Observation Services | 800 | 744 | $2,667.41 | $2,090.36 |
| APC 5302 Level 2 Upper GI Procedures | 661 | 589 | $1,859.50 | $1,444.50 |
| APC 5373 Level 3 Urology and Related Services | 534 | 441 | $1,904.94 | $1,516.28 |
| APC 5503 Level 3 Extraocular, Repair, and Plastic Eye Procedures | 466 | 417 | $2,277.39 | $1,780.31 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 427 | 397 | $1,543.93 | $1,219.56 |
| APC 5153 Level 3 Airway Endoscopy | 427 | 269 | $1,456.99 | $1,264.08 |
| APC 5492 Level 2 Intraocular Procedures | 420 | 348 | $3,937.36 | $3,116.50 |
| APC 5375 Level 5 Urology and Related Services | 310 | 286 | $5,041.80 | $3,917.51 |
| APC 5431 Level 1 Nerve Procedures | 248 | 189 | $1,277.43 | $1,406.61 |
| APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage | 237 | 182 | $2,722.34 | $2,141.49 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 40 | $2.8M |
| Pfizer Inc. PFE | 100 | $1.9M |
| Janssen Research & Development, LLC JNJ | 123 | $1.6M |
| AstraZeneca Pharmaceuticals LP AZN | 21 | $1.5M |
| Genentech, Inc. ROG.SW | 78 | $1.5M |
| Amgen Inc. AMGN | 25 | $1.1M |
| Abbvie Inc. ABBV | 113 | $1.0M |
| AstraZeneca UK Limited AZN | 5 | $798K |
| Novo Nordisk AS NVO | 7 | $766K |
| E.R. Squibb & Sons, L.L.C. BMY | 13 | $682K |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Uci Health-Orange is a government-owned short-term acute care hospital in Orange, CA with 911 beds, part of University of California Irvine and a 4-star overall rating.
Uci Health-Orange in Orange, CA has 911 beds (fiscal year 2025 cost report); 415 beds are certified for Medicare. It discharged 30,155 inpatients that year, with 92.1% of its beds in use on average.
In fiscal year 2025 (ending 2025-06-30), Uci Health-Orange reported net patient revenue of $2.54B and operating expenses of $2.70B, a margin on patient care of -6.1%. After other income and expenses its net income was -$155.7M (-6.1% of revenue), so it lost money that year.
Uci Health-Orange is part of University of California Irvine, a health system with 2 hospitals based in Oakland, CA. It is a government-owned hospital.
Uci Health-Orange has an overall rating of 4 out of 5 stars in the official hospital quality ratings. Patients rate it 2 out of 5 stars in the patient survey. 3 death rate measures are better and 0 worse than the national rate.
Yes, Uci Health-Orange provides emergency services.
2,561 Medicare clinicians list Uci Health-Orange as a hospital they work at, most often in Internal Medicine, Nurse Practitioner, Diagnostic Radiology.
In 2024, Uci Health-Orange had 3,680 Medicare inpatient stays in 126 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 423 stays; Medicare paid $27,059.05 per stay on average, compared with $15,524.21 across all hospitals.
In 2025, companies reported $23.0M in payments to Uci Health-Orange as a teaching hospital ($2.4M general and $20.6M for research) from 143 companies.